(Circulation. 1999;99:2791-2797.)
© 1999 American Heart Association, Inc.
Basic Science Reports |
Acetylsalicylic Acid Reduces Vegetation Bacterial Density, Hematogenous Bacterial Dissemination, and Frequency of Embolic Events in Experimental Staphylococcus aureus Endocarditis Through Antiplatelet and Antibacterial Effects
Presented in part at the 71st Scientific Sessions of the American Heart Association, Dallas, Tex, November 8–11, 1998, and published in abstract form (Circulation. 1998;98[suppl I]:I-700.)
From the Division of Adult Infectious Diseases (L.I.K., M.R.Y., S.G.F., A.S.B.) and Division of Cardiology (S.M.S.), St. John's Cardiovascular Research Center, Harbor–UCLA Medical Center, Torrance, Calif; UCLA School of Medicine (M.R.Y., S.M.S., S.G.F., A.S.B.), Los Angeles, Calif; Department of Pathology (C.C.N.), Cedars–Sinai Medical Center, Los Angeles, Calif; and Veterans Affairs Medical Center and University of California San Francisco (P.M.S.), San Francisco, Calif.
Correspondence to Leon Iri Kupferwasser, MD, Division of Infectious Diseases, LAC–Harbor UCLA Medical Center, 1000 W Carson St, Torrance, CA 90509 . E-mail kupferwasser{at}humc.edu
Background—Platelets are integral to cardiac vegetations that evolve in infectious endocarditis. It has been postulated that the antiplatelet aggregation effect of aspirin (ASA) might diminish vegetation evolution and embolic rates.
Methods and Results—Rabbits with Staphylococcus aureus endocarditis were given either no ASA (controls) or ASA at 4, 8, or 12 mg · kg-1 · d-1 IV for 3 days beginning 1 day after infection. Vegetation weights and serial echocardiographic vegetation size, vegetation and kidney bacterial densities, and extent of renal embolization were evaluated. In addition, the effect of ASA on early S aureus adherence to sterile vegetations was assessed. In vitro, bacterial adherence to platelets, fibrin matrices, or fibrin-platelet matrices was quantified with either platelets exposed to ASA or S aureus preexposed to salicylic acid (SAL). ASA at 8 mg · kg-1 · d-1 (but not at 4 or 12 mg · kg-1 · d-1) was associated with substantial decreases in vegetation weight (P<0.05), echocardiographic vegetation growth (P<0.001), vegetation (P<0.05) and renal bacterial densities and renal embolic lesions (P<0.05) versus controls. Diminished aggregation resulted when platelets were preexposed to ASA or when S aureus was preexposed to SAL (P<0.05). S aureus adherence to sterile vegetations (P<0.05) or to platelets in suspension (P<0.05), fibrin matrices (P<0.05), or fibrin-platelet matrices (P<0.05) was significantly reduced when bacteria were preexposed to SAL.
Conclusions—ASA reduces several principal indicators of severity and metastatic events in experimental S aureus endocarditis. These benefits involve ASA effects on both the platelet and the microbe.
Key Words: aspirin • embolism • endocarditis • platelets • fibrin
This article has been cited by other articles:
 |
|
 |
|
  M. B. K. Bandara, H. Zhu, P. R. Sankaridurg, and M. D. P. Willcox Salicylic Acid Reduces the Production of Several Potential Virulence Factors of Pseudomonas aeruginosa Associated with Microbial Keratitis. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4453 - 4460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Palma, A. Bayer, L. I. Kupferwasser, T. Joska, M. R. Yeaman, and A. Cheung Salicylic Acid Activates Sigma Factor B by rsbU-Dependent and -Independent Mechanisms. J. Bacteriol., August 1, 2006; 188(16): 5896 - 5903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Prithiviraj, H. P. Bais, T. Weir, B. Suresh, E. H. Najarro, B. V. Dayakar, H. P. Schweizer, and J. M. Vivanco Down Regulation of Virulence Factors of Pseudomonas aeruginosa by Salicylic Acid Attenuates Its Virulence on Arabidopsis thaliana and Caenorhabditis elegans Infect. Immun., September 1, 2005; 73(9): 5319 - 5328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Domanski, P. R. Patel, A. S. Bayer, L. Zhang, A. E. Hall, P. J. Syribeys, E. L. Gorovits, D. Bryant, J. H. Vernachio, J. T. Hutchins, et al. Characterization of a Humanized Monoclonal Antibody Recognizing Clumping Factor A Expressed by Staphylococcus aureus Infect. Immun., August 1, 2005; 73(8): 5229 - 5232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Baddour, W. R. Wilson, A. S. Bayer, V. G. Fowler Jr, A. F. Bolger, M. E. Levison, P. Ferrieri, M. A. Gerber, L. Y. Tani, M. H. Gewitz, et al. Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America Circulation, June 14, 2005; 111(23): e394 - e434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Clifton, E. Rydkina, R. S. Freeman, and S. K. Sahni NF-{kappa}B Activation during Rickettsia rickettsii Infection of Endothelial Cells Involves the Activation of Catalytic I{kappa}B Kinases IKK{alpha} and IKK{beta} and Phosphorylation-Proteolysis of the Inhibitor Protein I{kappa}B{alpha} Infect. Immun., January 1, 2005; 73(1): 155 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Niemann, N. Spehr, H. Van Aken, E. Morgenstern, G. Peters, M. Herrmann, and B. E. Kehrel Soluble Fibrin Is the Main Mediator of Staphylococcus aureus Adhesion to Platelets Circulation, July 13, 2004; 110(2): 193 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-Q. Xiong, A. S. Bayer, M. R. Yeaman, W. van Wamel, A. C. Manna, and A. L. Cheung Impacts of sarA and agr in Staphylococcus aureus Strain Newman on Fibronectin-Binding Protein A Gene Expression and Fibronectin Adherence Capacity In Vitro and in Experimental Infective Endocarditis Infect. Immun., March 1, 2004; 72(3): 1832 - 1836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Task Force Members, D. Horstkotte, F. Follath, E. Gutschik, M. Lengyel, A. Oto, A. Pavie, J. Soler-Soler, G. Thiene, A. von Graevenitz, et al. Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis Executive Summary: The Task Force on Infective Endocarditis of the European Society of Cardiology Eur. Heart J., February 1, 2004; 25(3): 267 - 276. [Full Text] [PDF]
|
|
|
|
 |
|
 K.-L. Chan, J. G. Dumesnil, B. Cujec, A. J. Sanfilippo, J. Jue, M. A. Turek, T. I. Robinson, D. Moher, and Investigators of the Multicenter Aspirin Study in A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis J. Am. Coll. Cardiol., September 3, 2003; 42(5): 775 - 780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Homma and C. Grahame-Clarke Toward reducing embolic complications from endocarditis J. Am. Coll. Cardiol., September 3, 2003; 42(5): 781 - 783. [Full Text] [PDF]
|
|
|
|
 |
|
 U. Sjobring, U. Ringdahl, and Z. M. Ruggeri Induction of platelet thrombi by bacteria and antibodies Blood, December 15, 2002; 100(13): 4470 - 4477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. I. Kupferwasser, M. R. Yeaman, S. M. Shapiro, C. C. Nast, and A. S. Bayer In Vitro Susceptibility to Thrombin-Induced Platelet Microbicidal Protein Is Associated With Reduced Disease Progression and Complication Rates in Experimental Staphylococcus aureus Endocarditis: Microbiological, Histopathologic, and Echocardiographic Analyses Circulation, February 12, 2002; 105(6): 746 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Mylonakis and S. B. Calderwood Infective Endocarditis in Adults N. Engl. J. Med., November 1, 2001; 345(18): 1318 - 1330. [Full Text] [PDF]
|
|
|
|
|
|
S. Shapiro and L. I. Kupferwasser Echocardiography predicts embolic events in infective endocarditis J. Am. Coll. Cardiol., March 15, 2001; 37(4): 1077 - 1079. [Full Text] [PDF]
|
|